A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.
暂无分享,去创建一个
A. de la Chapelle | A. Wagner | R. Fodde | P. Franken | H. Lynch | K. Sweet | S. Coronel | H. Hampel | R. Okimoto | J. Lynch | J. Wijnen | H. M. van der Klift | Alicia Barrows
[1] H. Nakagawa,et al. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques , 2003, Human mutation.
[2] A. de la Chapelle,et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. , 2003, American journal of human genetics.
[3] P. Gregersen,et al. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. , 2002, American journal of human genetics.
[4] J. Terdiman,et al. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma , 2002, Cancer.
[5] A. Wagner,et al. A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred , 2002, Genes, chromosomes & cancer.
[6] K. Kinzler,et al. Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements. , 2002, Cancer research.
[7] D. Zwijnenburg,et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.
[8] R. Chadwick,et al. Recurrent germline mutation in MSH2arises frequently de novo , 2000, Journal of medical genetics.
[9] L. Aaltonen,et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] L. Aaltonen,et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.
[11] A. Chapelle,et al. Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily. , 2000 .
[12] A. de la Chapelle,et al. Genetic susceptibility to non-polyposis colorectal cancer , 1999, Journal of medical genetics.
[13] P. Møller,et al. Familial endometrial cancer in female carriers of MSH6 germline mutations , 1999, Nature Genetics.
[14] D. Evans,et al. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer , 1999, Journal of medical genetics.
[15] P. Møller,et al. MSH2 genomic deletions are a frequent cause of HNPCC , 1998, Nature Genetics.
[16] J. Struewing,et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation , 1998, The Lancet.
[17] F. Wright,et al. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] L. Aaltonen,et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.
[19] J. Mathers,et al. Diet and cancer prevention: the Concerted Action Polyp Prevention (CAPP) Studies , 1998, Proceedings of the Nutrition Society.
[20] K. Kinzler,et al. The Genetic Basis of Human Cancer , 1997 .
[21] P. Møller,et al. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. , 1997, American journal of human genetics.
[22] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[23] Chapelle,et al. Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. , 1996, American journal of human genetics.
[24] S. Antonarakis,et al. Complex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation. , 1996, Journal of medical genetics.
[25] A. Cats,et al. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. , 1996, American journal of human genetics.
[26] K. Kinzler,et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer , 1995, Nature Medicine.
[27] F. Collins,et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals , 1995, Nature Genetics.
[28] J. Joyce,et al. A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome , 1995, The Lancet.
[29] H T Lynch,et al. Hereditary Nonpolyposis Colorectal Cancer Patients Replication Errors in Benign and Malignant Tumors from , 2006 .
[30] A. Berchuck,et al. Genetic instability of microsatellites in endometrial carcinoma. , 1993, Cancer research.
[31] J. Weber,et al. Genetic mapping of a locus predisposing to human colorectal cancer. , 1993, Science.
[32] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[33] V. McKusick,et al. GENETIC STUDIES OF THE AMISH, BACKGROUND AND POTENTIALITIES. , 1964, Bulletin of the Johns Hopkins Hospital.